This rhodium-catalyzed reaction produces α- and β-amino acids in a solvent-controlled manner, highlighting efficiency and versatility.
Non-natural α- and β-amino acids are pivotal building blocks in medicinal chemistry and bioactive molecule discovery. Herein, we report a rhodium-catalyzed, solvent-directed, regiodivergent carboamidation of β,γ-unsaturated alkenyl carboxylic acid for the programmable synthesis of both α- and β-amino acids. This strategy leverages β,γ-unsaturated alkenyl carboxylic acids, organoboronic acids, and dioxazolones as readily available substrates, achieving broad substrate scope with high efficiency (average yield 60%) and excellent functional group tolerance. The solvent system (HFIP vs THF) serves as a simple switch to precisely control regioselectivity (α:β up to >20:1 or β:α up to >20:1), bypassing traditional protecting-group manipulations. Notably, this protocol enables concise two-step synthesis of N-Ac sitagliptin and rapid access to diverse peptidomimetics, showcasing its potential in streamlining the development of pharmaceuticals and bioactive probes. DFT calculations reveal distinct energy barriers for the rate-determining steps of the two pathways in HFIP and THF, rationalizing the solvent-controlled selectivity.
No takes yet. Share an insight, caveat, or question.
Jia et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: